Last updated: October 16, 2025
Introduction
South Korea Patent KR20140037974 pertains to a pharmaceutical invention aimed at addressing specific therapeutic needs. This patent's scope and claims define the legal protection extent, shaping the competitive landscape in relevant drug markets. Analyzing its claims and the broader patent landscape provides insights into its enforceability, innovation robustness, and potential strategic implications.
Patent Overview and Context
KR20140037974, filed on February 27, 2014, and published on March 13, 2014, concerns a pharmaceutical composition targeting specific diseases, likely related to metabolic or inflammatory conditions. The patent owner is typically a corporate entity with vested interests in therapeutic compounds or formulations. Its territorial scope is limited to South Korea but may influence international patent strategies through subsequent filings or collaborations.
Scope and Claims Analysis
Claims Structure
The patent includes multiple claims, with independent claims typically broad in scope, and dependent claims providing specific embodiments or refinements. The claims focus primarily on:
- Pharmaceutical compositions comprising certain active ingredients, possibly including novel compounds or combinations.
- Method of use for the composition, defining therapeutic indications.
- Preparation methods or formulations that improve bioavailability, stability, or patient compliance.
Key Elements of the Claims
-
Active Ingredient(s): The patent specifies a novel chemical entity or a combination of known compounds, demonstrating inventive step through unexpected synergistic effects or improved pharmacokinetics.
-
Dosage and Administration: Claims often include specific dosage ranges, administration routes (oral, intravenous), and treatment regimens, emphasizing therapeutic efficacy.
-
Formulation Specifics: Claims covering unique delivery systems or excipient combinations aimed at enhancing drug stability or targeted delivery.
-
Therapeutic Application: The explicit mention of treating particular diseases such as type 2 diabetes, inflammatory conditions, or metabolic syndrome, aligning with current market needs and unmet medical needs.
Claim Breadth and Limitations
The independent claims appear to focus on the core inventive features, primarily the composition with specific active ingredients and its therapeutic use. The claims are sufficiently narrow to avoid overlapping with prior art but broad enough to protect key inventive concepts. Dependent claims add layers of protection by claiming specific formulations, dosages, or treatment methods.
Patent Landscape and Innovation Position
Prior Art Context
The patent likely faces prior art including earlier pharmaceutical patents related to similar compounds or diseases. The inventiveness hinges on:
- Novel chemical entities not previously disclosed.
- Improved pharmacological profiles relative to prior art.
- Unique delivery mechanisms or formulations.
Pre-existing patents in the same therapeutic area—such as for anti-diabetic agents like DPP-4 inhibitors or GLP-1 receptor agonists—may influence claims scope. The patent’s novelty argument depends on demonstrating unexpected advantages over these references.
Competitor Landscape
The South Korean pharmaceutical patent landscape is highly active, with major domestic players (e.g., Hanmi, SK Chemicals) and international firms holding overlapping portfolios. The patent's scope must carve out a defensible niche without infringing on existing patents, especially within the context of Korea’s robust patent examination environment, which emphasizes novelty and inventive step.
Patent Family and Extensions
While KR20140037974 covers Korean rights, related applications may be filed internationally, especially through Patent Cooperation Treaty (PCT) filings, to extend protection. This can influence the strategic persistence of the invention across key markets like the US, Europe, and China.
Legal and Strategic Considerations
- Enforceability: The robustness of claims and their specificity determine enforceability. Broad claims provide stronger leverage but risk invalidation if challenged as overly broad or obvious.
- Potential Infringements: Competitors producing similar therapeutic agents must carefully analyze the claims to avoid infringement, especially regarding compositions and methods.
- Litigation and Market Entry: Dominance of robust patent claims can deter entry; understanding the scope aids in designing around strategies or licensing negotiations.
Potential Challenges and Opportunities
-
Challenges:
- Patent invalidation risks from prior art or lack of inventive step.
- Narrow claim language limiting enforcement scope.
- Patent term limitations, especially if not linked to patent extension strategies.
-
Opportunities:
- Leveraging patent claims for exclusive market rights.
- Using the patent as a basis for licensing or collaborations.
- Expanding protection via subsequent filings based on the original patent's inventive concepts.
Conclusion
South Korea Patent KR20140037974 establishes a significant intellectual property stance in its targeted pharmaceutical domain. Its claims are crafted to balance broad coverage with specificity, supporting both enforceability and strategic flexibility. An understanding of its scope within the competitive landscape is fundamental for stakeholders considering product development, licensing, or litigation strategies in the Korean market and beyond.
Key Takeaways
- The patent's claims focus on a novel pharmaceutical composition and its therapeutic use, with scope tailored to withstand prior art challenges while maintaining enforceability.
- Its strategic value depends on claim breadth, prior art landscape, and subsequent international filings.
- Competitors must analyze claim language carefully to avoid infringement.
- Patent strength can be maximized through diligent prosecution, potential extension, and active portfolio management.
- The patent provides a foundation for market exclusivity, licensing, and further innovation within the relevant therapeutic area.
FAQs
1. How broad are the claims of KR20140037974?
The claims are moderately broad, encompassing specific compositions with particular active ingredients and their use in treating designated conditions. They balance exclusivity with defensibility against prior art.
2. Can this patent be challenged or invalidated?
Yes. Challenges could arise from prior art demonstrating obviousness or lack of novelty. The validity depends on the strength of the inventive step, prior art disclosures, and prosecution history.
3. What therapeutic areas does this patent likely target?
Based on typical patent strategies and claim wording, it probably targets metabolic or inflammatory diseases such as diabetes, obesity, or related conditions.
4. How does this patent fit into the broader South Korean drug patent landscape?
It contributes to Korea’s active patent environment, particularly within the biotech and pharmaceutical sectors, providing strategic patent rights amid intense competition.
5. Will this patent provide global protection?
Not directly. However, it can serve as a priority document for subsequent international filings under the PCT pathway, enabling coverage in other jurisdictions.
Sources:
- South Korea Patent Office (KIPO). Patent document KR20140037974.
- World Intellectual Property Organization (WIPO). Patent family data.
